Compare Lowest Price Weight Loss Surgery in France
gastric sleeve surgery in France
15 minute ‘sleeve’ implant to revolutionise type 2 diabetes treatment
A wide-ranging study is to provide “definitive evidence” that the tiny EndoBarrier could be a more effective treatment than diet, exercise and medication in the fight against the disease.
Medics have hailed the implant as potentially a game-changer while Diabetes UK said the new study could prove “vital” in treating a disease which impacts nearly 3m people in the UK.
Professor Julian Teare, who is leading the new study into EndoBarrier, has lauded the treatment’s ability to bypass surgery.
Professor Teare said it could help ” treat thousands more people living with type 2 diabetes every year”.
EndoBarrier has already been successfully trailed during a 12-week study, which boasted remarkable results.
Patients showed a dramatic drop in blood glucose levels within weeks of receiving the implant reducing the need for diabetes medication.
Furthermore, patients in the trial also achieved significant weight loss similar to that seen following gastric band surgery.
Now, the treatment is being tested over a 24-month period before its expected roll out into the market in the next few years.
James Byrne, a consultant surgeon and co-lead on the 12-week study, said: “We know weight loss surgery is currently the most effective and longest-standing treatment option for type 2 diabetes.
“However, it is not the right approach for everyone and will not significantly impact the epidemic of type 2 diabetes we see in the UK